BIOLASE, Inc. (BIOL)
NASDAQ: BIOL · IEX Real-Time Price · USD
0.137
+0.001 (0.44%)
Apr 16, 2024, 9:40 AM EDT - Market open

BIOLASE Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1995
Net Income
-37.62-28.85-16.7-34.21-17.86-21.52-20.83-17.56-20.28-18.93
Upgrade
Depreciation & Amortization
2.80.50.40.50.980.951.21.050.880.7
Upgrade
Share-Based Compensation
1.232.411.833.372.742.772.213.073.351.36
Upgrade
Other Operating Activities
2.51-1.04-2.780.171.393.66-4.970.66-1.720.67
Upgrade
Operating Cash Flow
-14.09-26.76-16.71-12.8-12.75-14.15-18.41-10.6-17.77-16.2
Upgrade
Capital Expenditures
-1.13-3.73-0.71-0.1-0.21-0.52-0.75-1.41-1.78-0.2
Upgrade
Investing Cash Flow
-1.13-3.73-0.71-0.1-0.21-0.52-0.75-1.41-1.78-0.2
Upgrade
Share Issuance / Repurchase
9.675.629.985.688.35-0.1621.769.520.0451.43
Upgrade
Debt Issued / Paid
-0.17-1-0.032.312.3711.4-0.15-0.17-0.11-4.68
Upgrade
Other Financing Activities
7.93--16.36-----0.04-
Upgrade
Financing Cash Flow
17.434.629.9524.3510.7211.2421.629.35-0.1146.75
Upgrade
Exchange Rate Effect
0.17-0.11-0.240.32-0.02-0.110.26-0.06-0.21-0.23
Upgrade
Net Cash Flow
2.39-25.9912.311.78-2.26-3.542.72-2.72-19.8630.12
Upgrade
Free Cash Flow
-15.22-30.49-17.42-12.89-12.95-14.67-19.16-12.01-19.55-16.4
Upgrade
Free Cash Flow Margin
-30.96%-62.91%-44.44%-56.59%-34.27%-31.78%-40.83%-23.18%-40.33%-34.41%
Upgrade
Free Cash Flow Per Share
-11.91-441.86-295.20-527.24-1395.80-1781.30-3246.74-2474.76-4199.78-4852.91
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).